ovarian-cancer

Documents about ovarian-cancer

• Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer#889718ClinicalTrials.gov
• Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer#888794ClinicalTrials.gov
• Tumor Microenvironment in Ovarian Cancer#863099ClinicalTrials.gov
• Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass#913643ClinicalTrials.gov
• Specimen and Data Study for Ovarian Cancer Early Detection and Prevention#907367ClinicalTrials.gov
• Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer#825575ClinicalTrials.gov
• S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer#807707ClinicalTrials.gov
• Toremifene in Treating Patients With Ovarian Cancer#905486ClinicalTrials.gov
• Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer#860307ClinicalTrials.gov
• Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer#892735ClinicalTrials.gov
• Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer#801864ClinicalTrials.gov
• Yoga in Relieving Fatigue in Patients Undergoing Chemotherapy for Ovarian Cancer#851093ClinicalTrials.gov
• Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer#885563ClinicalTrials.gov
• Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer#860807ClinicalTrials.gov
• Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer#914214ClinicalTrials.gov
• A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)#849794ClinicalTrials.gov
• A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)#886536ClinicalTrials.gov
• The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer#123449ClinicalTrials.gov
• An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer#813062ClinicalTrials.gov
• Vaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers#805709ClinicalTrials.gov
• p53 Activation in Platinum-Resistant High Grade Serous Ovarian Cancer, a Study of PLD With APR-246#879412ClinicalTrials.gov
• Salvage Ovarian FANG™ Vaccine + Bevacizumab#127703ClinicalTrials.gov
• A Trial of Vigil for Participants With Ovarian Cancer#256968ClinicalTrials.gov
• Advanced Ovarian Cancer and Sexuality Phase 1#853205ClinicalTrials.gov
• Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)#863634ClinicalTrials.gov
• Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom#810902ClinicalTrials.gov
• Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma#883867ClinicalTrials.gov
• Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer#889803ClinicalTrials.gov
• Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer#901060ClinicalTrials.gov
• Screening Women at High Genetic Risk for Ovarian Cancer#865850ClinicalTrials.gov
• Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer#885888ClinicalTrials.gov
• CA125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women#917014ClinicalTrials.gov
• Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer#834441ClinicalTrials.gov
• Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer#845797ClinicalTrials.gov
• Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer#876866ClinicalTrials.gov
• Paclitaxel-Loaded Polymeric Micelle and Carboplatin as First-Line Therapy in Treating Patients With Advanced Ovarian Cancer#831593ClinicalTrials.gov
• Prehabilitation in Gynaecological Cancer Patients#909485ClinicalTrials.gov
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer#854505ClinicalTrials.gov
• p53 Vaccine for Ovarian Cancer#460097ClinicalTrials.gov
• Open Label Immunotherapy Trial for Ovarian Cancer#628587ClinicalTrials.gov
• Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer#871376ClinicalTrials.gov
• Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants#907114ClinicalTrials.gov
• A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian Cancer#837541ClinicalTrials.gov
• Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer#900808ClinicalTrials.gov
• AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)#834598ClinicalTrials.gov
• Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer#892738ClinicalTrials.gov
• Patient Reported Symptoms in Ovarian Cancer (PRECISION)#826095ClinicalTrials.gov
• Combination of Cryosurgey and NK Immunotherapy for Recurrent Ovarian Cancer#846259ClinicalTrials.gov
• Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian Cancer#846974ClinicalTrials.gov
• Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer#915109ClinicalTrials.gov